| |
| |
|
| Insider
Information: |
Or Yat Sun |
| Relationship: |
Chief Scientific Officer |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
373,295 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,528,068 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
373,295 |
|
|
| Total
Value |
$4,528,068 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 37.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enanta Pharmaceuticals Inc |
ENTA |
Chief Scientific Officer |
2024-02-12 |
373,295 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
50 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific OfficerOffice |
• – – |
2013-03-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
79,991 |
|
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2014-01-03 |
4 |
OE |
$0.73 |
$94,582 |
D/D |
129,087 |
209,078 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2014-03-24 |
4 |
AS |
$38.42 |
$393,352 |
D/D |
(10,000) |
199,078 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2014-04-01 |
4 |
AS |
$38.92 |
$391,622 |
D/D |
(10,000) |
189,078 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2014-05-01 |
4 |
AS |
$36.29 |
$184,914 |
D/D |
(5,000) |
184,078 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2014-06-02 |
4 |
AS |
$37.38 |
$187,821 |
D/D |
(5,000) |
179,078 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2014-07-01 |
4 |
AS |
$42.20 |
$211,218 |
D/D |
(5,000) |
174,078 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2014-08-05 |
4 |
OE |
$1.29 |
$14,416 |
D/D |
11,149 |
185,227 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2014-08-13 |
4 |
AS |
$39.48 |
$197,441 |
D/D |
(5,000) |
180,227 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2015-01-06 |
4 |
OE |
$1.21 |
$69,999 |
D/D |
58,004 |
238,231 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2015-05-11 |
4 |
AS |
$36.13 |
$289,045 |
D/D |
(8,000) |
230,231 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2015-06-05 |
4 |
AS |
$42.02 |
$451,662 |
D/D |
(10,750) |
219,481 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2015-06-11 |
4 |
AS |
$42.47 |
$159,265 |
D/D |
(3,750) |
215,731 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2015-07-13 |
4 |
AS |
$46.24 |
$173,594 |
D/D |
(3,750) |
211,981 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2015-08-10 |
4 |
AS |
$42.57 |
$160,884 |
D/D |
(3,750) |
208,231 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2016-01-04 |
4 |
OE |
$1.51 |
$199,445 |
D/D |
78,565 |
286,796 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2016-01-19 |
4 |
OE |
$2.54 |
$109,146 |
D/D |
42,922 |
329,718 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2016-11-29 |
4 |
S |
$31.44 |
$437,609 |
D/D |
(13,921) |
315,797 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2017-01-04 |
4 |
AS |
$35.09 |
$488,505 |
D/D |
(13,921) |
301,876 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2017-02-13 |
4 |
D |
$29.82 |
$32,170 |
D/D |
(1,079) |
303,717 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2017-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,920 |
304,796 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,869 |
312,586 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2018-02-12 |
4 |
D |
$76.85 |
$204,869 |
D/D |
(2,666) |
309,920 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2019-02-11 |
4 |
OE |
$11.77 |
$342,402 |
D/D |
25,977 |
335,897 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2019-02-11 |
4 |
AS |
$88.66 |
$2,474,737 |
D/D |
(27,684) |
308,213 |
0 |
- |
|
50 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
